Good evening :)
Add to Watchlist
Share
Home
Portfolio
Search
GoldGold
More

HDFC Pharma and Healthcare Fund(IDCW)

IDCW
16.600.96% (+0.16)
Investment Checklist

Returns

Fund's average annual rolling returns over the last three years is compared against the funds from the same category

Insufficient Data

Expense Ratio

Expense Ratio is the fee paid by investors of Mutual Funds. Fund's expense ratio is compared against the expense ratio of other funds in the same category to check if the fund is charging more or less compared to other funds in the same category

Less expense ratio implies better returns over the long term

Return vs FD Rates

If fund's return is lower than the average fixed deposit rates offered by banks, investors are better off investing the amount in a FD

Insufficient Data

Red Flags

We check for various red flags on fund's portfolio holdings like - ratings for debt securities, pledging of promoter shares in the company, default probabiity of the company, stocks presense in negative lists published by the exchanges etc. Checkout the Holdings section in the Portfolio tab for full list of securties with red flags

Significant holdings have underlying redflags

HDFC Pharma and Healthcare Fund(IDCW)

IDCW
EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,302 Cr
Very High RiskPrinciple investment will be at very high risk
16.600.96% (+0.16)

Price Chart

High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP
Investment Checklist

Returns

Fund's average annual rolling returns over the last three years is compared against the funds from the same category

Insufficient Data

Expense Ratio

Expense Ratio is the fee paid by investors of Mutual Funds. Fund's expense ratio is compared against the expense ratio of other funds in the same category to check if the fund is charging more or less compared to other funds in the same category

Less expense ratio implies better returns over the long term

Return vs FD Rates

If fund's return is lower than the average fixed deposit rates offered by banks, investors are better off investing the amount in a FD

Insufficient Data

Red Flags

We check for various red flags on fund's portfolio holdings like - ratings for debt securities, pledging of promoter shares in the company, default probabiity of the company, stocks presense in negative lists published by the exchanges etc. Checkout the Holdings section in the Portfolio tab for full list of securties with red flags

Significant holdings have underlying redflags

EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,302 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.9852.254.06
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.4754.303.35

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
IDCW0 yrs1.00%
1% on or before 30D Nil after 30D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 100
Initial: ₹ 100 Incremental: ₹ 100
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care

Returns

Scheme

Ratios

Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
HDFC Pharma and Healthcare Fund(IDCW)65.89%—64.76%
Nippon India Pharma Fund(IDCW)43.06%16.65%12.38%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout)51.92%13.83%17.47%
SBI Healthcare Opp Fund(IDCW-Payout)53.91%23.15%17.51%

Price Comparison

Compare HDFC Pharma and Healthcare Fund(IDCW) with any MF, ETF, stock or index
Compare HDFC Pharma and Healthcare Fund(IDCW) with any MF, ETF, stock or index
HDFC Pharma and Healthcare Fund(IDCW)
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Dec 2023

Mar 2024

Jun 2024

Sep 2024

ACTUAL
Cash & EquivalentsEquity1.40%98.60%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Tickertape Separator

Sector Distribution

MiscellaneousOthersLabs & Life Sciences ServicesPharmaceuticals1.57 %1.72 %19.15 %77.56 %

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Tickertape Separator

Sector Weightage

Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24N/AN/A69.66%71.43%75.78%77.56%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Sun Pharmaceutical Industries Ltd
    SUNPHARMA
    3M change : -0.98 %

    Holdings

    11.56 %

    -0.98 %
  • Divi's Laboratories Ltd
    DIVISLAB
    3M change : 5.32 %

    Holdings

    7.35 %

    5.32 %
  • Cipla Ltd
    CIPLA
    3M change : -0.92 %

    Holdings

    5.48 %

    -0.92 %

AMC Profile

HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).

  • No.of Schemes

    82

  • Total AUM

    ₹ 7,51,572.17 Cr.

Fund Manager Profile

Nikhil Mathur

AUM:  ₹1,302.67 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 7yrs

Qualification

PGDM - IMT, B.E. (Civil), CFA (USA)

Past Experience

Over 7 years of experience in equity research and 2 years in financial advisory.

Funds Managed (4)

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
News Thumbnail

#FundTalk - HDFC Pharma and Healthcare Fund NFO discussion with Mr. Nikhil Mathur

1 year ago•HDFC Mutual Fund